Quarterly report pursuant to Section 13 or 15(d)

Collaboration and Research Arrangements (Tables)

v3.21.2
Collaboration and Research Arrangements (Tables)
9 Months Ended
Sep. 30, 2021
Collaborative Arrangement Disclosure [Abstract]  
Schedule of Change in Accounts Receivable, Contract Assets and Liabilities

The following table presents the changes in accounts receivable, contract assets and liabilities for the nine months ended September 30, 2021 (in thousands):

 

 

 

Balance at

December

31, 2020

 

 

Additions

 

 

Deductions

 

 

Balance at
September 30,
 2021

 

Accounts receivable and contract assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Billed receivables from collaboration partners

 

$

7

 

 

$

7,270

 

 

$

(7,277

)

 

$

 

Unbilled receivables from collaboration partners

 

 

2,324

 

 

 

8,431

 

 

 

(7,123

)

 

 

3,632

 

Total accounts receivable and contract assets

 

$

2,331

 

 

$

15,701

 

 

$

(14,400

)

 

$

3,632

 

Contract liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue - Incyte

 

$

5,365

 

 

$

 

 

$

(2,766

)

 

$

2,599

 

Deferred revenue - GBT

 

 

16,721

 

 

 

145

 

 

 

(4,490

)

 

 

12,376

 

Total contract liabilities

 

$

22,086

 

 

$

145

 

 

$

(7,256

)

 

$

14,975